COCRYSTAL PHARMA INC (COCP)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Sam Lee
Employees:
10
1860 MONTREAL ROAD, TUCKER, GA 30084
(425) 398-7178

Cocrystal Pharma, Inc. focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company develops CC-31244, a HCV non-nucleoside polymerase inhibitor that has completed Phase II a clinical trial to treat HCV infection.

Data derived from most recent annual or quarterly report
Market Cap 19.025 Million Shares Outstanding10.174 Million Avg 30-day Volume 38.135 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-3
Price to Revenue0.0 Debt to Equity0.0 EBITDA-19.504 Million
Price to Book Value0.6936 Operating Margin0.0 Enterprise Value-8.439 Million
Current Ratio22.534 EPS Growth0.564 Quick Ratio20.428
1 Yr BETA 0.5571 52-week High/Low 3.72 / 1.74 Profit Margin0.0
Operating Cash Flow Growth-40.7356 Free Cash Flow to Firm (FCFF) TTM -17.655 Million Free Cash Flow to Equity (FCFE) TTM-13.885 Million
Altman Z-Score-3.4815
Earnings Report2023-11-14
View SEC Filings from COCP instead.

View recent insider trading info

COCRYSTAL PHARMA INC YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding COCP (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding COCP

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-07-20 by JAPOUR ANTHONY J
  • 4: filed on 2023-07-20 by MARTIN JAMES JOSEPH
  • 4: filed on 2023-07-20 by KORNBERG ROGER D.
  • 4: filed on 2023-07-20 by LEE SAM
  • 3: filed on 2023-04-27 by HASSAN FRED
  • 4: filed on 2023-04-06 by FROST PHILLIP MD ET AL
  • 4: filed on 2021-08-23 by PFENNIGER RICHARD C JR
  • 3: filed on 2021-06-02 by PFENNIGER RICHARD C JR
  • 4: filed on 2021-05-06 by SCHINAZI RAYMOND F
  • 5: filed on 2021-02-12 by LEE SAM

    • Events (8k)

  • 8-K: filed on 2020-07-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-06-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2020-06-15:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2020-06-08:
    Item 1.02: Termination of a Material Definitive Agreement
  • 8-K: filed on 2020-05-11:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-04-22:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-04-20:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-03-30:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-03-13:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2020-03-09:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    FROST PHILLIP MD ET AL

    • Director
    • 10% Owner
    		 0 2023-07-18 2

    HASSAN FRED

    • Director
    		 0 2023-07-18 2

    PFENNIGER RICHARD C JR

    • Director
    		 0 2023-07-18 1

    RUBIN STEVEN D

    • Director
    		 0 2023-07-18 1

    KORNBERG ROGER D.

    • Director
    		 0 2023-07-18 1

    MARTIN JAMES JOSEPH CO-CEO AND CFO

    • Officer
    		 0 2023-07-18 1

    LEE SAM PRESIDENT AND CO-CEO

    • Officer
    		 0 2023-07-18 1

    JAPOUR ANTHONY J

    • Director
    		 0 2023-07-18 1

    FROST PHILLIP MD ET AL

    FROST GAMMA INVESTMENTS TRUST

    • Director
    • 10% Owner
    		 1,319,838 2023-04-04 2

    SCHINAZI RAYMOND F

    • 10% Owner
    		 7,674,960 2021-05-04 0

    WILCOX GARY CHIEF EXECUTIVE OFFICER

    • Officer
    		 0 2020-06-22 0

    BRADY TODD R.

    • Director
    		 0 2019-02-01 0

    HSIAO JANE PH D

    • Director
    		 0 2018-09-21 0

    BLOCK DAVID S

    • Director
    		 0 2018-09-21 0

    MECKLER JEFFREY A CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 657,161 2016-03-15 0

    DALE CURTIS INTERIM CFO

    • Officer
    		 100,000 2015-11-24 0

    MAYERS DOUGLAS L CHIEF MEDICAL OFFICER

    • Officer
    		 0 2015-10-01 0

    LINSCOTT WALT ADDISON GENERAL COUNSEL AND SECRETARY

    • Officer
    		 1,200,000 2015-07-21 0

    MCGUIRE GERALD A CHIEF FINANCIAL OFFICER

    • Officer
    		 200,000 2015-04-13 0

    OPKO HEALTH, INC.

    • 10% Owner
    		 18,696,301 2014-03-17 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    COCRYSTAL PHARMA INC COCP 2023-09-29 22:15:03 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 21:45:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 21:15:03 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 20:45:05 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 20:15:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 19:45:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 19:15:03 UTC 0.0 0.0 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 18:45:03 UTC 0.0 0.0 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 18:15:03 UTC 0.0 0.0 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 17:45:03 UTC 0.0 0.0 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 17:15:04 UTC 0.0 0.0 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 16:45:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 16:15:03 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 15:45:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 15:15:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 14:45:04 UTC -0.7978 6.1178 150000
    COCRYSTAL PHARMA INC COCP 2023-09-29 14:15:04 UTC -0.7978 6.1178 100000
    COCRYSTAL PHARMA INC COCP 2023-09-29 13:45:03 UTC -0.9115 6.2315 100000
    COCRYSTAL PHARMA INC COCP 2023-09-29 13:15:04 UTC -0.9115 6.2315 100000
    COCRYSTAL PHARMA INC COCP 2023-09-29 12:45:05 UTC -0.9115 6.2315 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    WhaleWisdom Logo

    Elevate your investments